Companies: 10,795·Total market cap: $144.5T
Karuna Therapeutics, Inc.

Karuna Therapeutics, Inc.

KRTXNASDAQHealthcare
$329.83
+$0.09(+0.03%)
Market Cap$12.6B
P/E Ratio—
52W High$329.99
52W Low$158.375
Overview

Karuna Therapeutics, Inc. (KRTX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001771917 · KRTX · NASDAQ · as of Jun 9, 2026

Filing snapshot

460
Total Filings
15-12G
Latest Form
2024-03-28
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001771917 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2024-03-14
Fiscal Year End
Mar 14, 2024
Accession No.
0000950170-24-031505
Primary Document
krtx-20231231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001771917 · Accession 0000950170-24-031505

Latest Key Filings

10-QQuarterly Report
10-Q
2023-11-02
View 10-Q on SEC
8-KCurrent Report
8-K
2024-03-18Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
15-12G15-12G
15-12G
2024-03-28
View
S-8 POSS-8 POS
S-8 POS
2024-03-18
View
S-8 POSS-8 POS
S-8 POS
2024-03-18
View
S-8 POSS-8 POS
S-8 POS
2024-03-18
View
S-8 POSS-8 POS
S-8 POS
2024-03-18
View
S-8 POSS-8 POS
S-8 POS
2024-03-18
View
25-NSE25-NSE
25-NSE
2024-03-18
View
POSASRPOSASR
POSASR
2024-03-18
View
8-KCurrent Report
8-K
2024-03-18
View
10-K/AAnnual Report (Amended)
10-K/A
2024-03-14
View
8-KCurrent Report
8-K
2024-03-14
View
8-KCurrent Report
8-K
2024-03-12
View
DEFA14AProxy Statement (Additional)
DEFA14A
2024-03-01
View
8-KCurrent Report
8-K
2024-03-01
View
10-KAnnual Report
10-K
2024-02-22
View
Showing 1–15 of 207 filingsForm 4 / 144 hidden· 460 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001771917  |  Exchange: NASDAQ · Healthcare

Karuna Therapeutics, Inc. (NASDAQ: KRTX) has submitted 460 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001771917, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Karuna Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Karuna Therapeutics, Inc. 10-K was filed on 2024-03-14 for fiscal year ending 2024. Historical KRTX 10-K annual reports are available from 2019 through 2024.

Investors researching Karuna Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
BDX SEC Filings →ROIV SEC Filings →ITCI SEC Filings →SWAV SEC Filings →CTLT SEC Filings →RXDX SEC Filings →IMGN SEC Filings →BPMC SEC Filings →
→ KRTX Financials→ KRTX Earnings→ KRTX Insider Trades

Frequently Asked Questions

KRTX SEC Filings · 8 questions

Karuna Therapeutics, Inc. (KRTX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 460 filings and access original documents at no cost. Karuna Therapeutics, Inc.'s CIK is 0001771917.

KRTX SEC filingsKaruna Therapeutics, Inc. SEC documentsfind KRTX 10-K